Novel Therapeutic Oxygen Delivery
Stabilizing and delivering oxygen for targeted clinical indications
Respirogen™ Lipid Oxygen Microbubble (OMB) technology provides novel systemic oxygen delivery to the body independent of the lungs. Hypoxia (low oxygen saturation) in lung injury patients can quickly lead to irreversible organ damage or death. OMB will reduce risk and cost of current ventilator and ECMO therapies.
Our Technology
Oxygen Microbubbles (OMBs) – Stabilized oxygen gas spheres delivered sterile to the physician. Every cell in the body requires oxygen to maintain correct homeostasis, and hypoxic conditions can quickly lead to irreversible organ damage or death. OMB technology has demonstrated the ability to deliver oxygen to the blood stream independent of the lungs.
Contact Us
Want to learn more about Respirogen or have a question about our approach? Use the contact form and let’s start a conversation.